Modeling complex neuropsychiatric disease with induced pluripotent stem cells

F1000 Biology Reports

Volumn 2, Issue 1, 2010, Pages

  Ross, P Joel ^a   Ellis, James ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DIFFERENTIATION; CHROMOSOME INACTIVATION; DISEASE MODEL; GENETIC MANIPULATION; HUMAN; MENTAL DISEASE; NEUROLOGIC DISEASE; NONHUMAN; PLURIPOTENT STEM CELL; RETT SYNDROME; REVIEW; X CHROMOSOME;

EID: 78650657519     PISSN: 17404118     EISSN: 1757594X     Source Type: Journal    
DOI: 10.3410/B2-84     Document Type: Review

References (31)

1. Burmeister M, McInnis MG, Zollner S: Psychiatric genetics: progress amid controversy. Nat Rev Genet 2008, 9:527-40. (Pubitemid 351972757)
2. Cook EH Jr, Scherer SW: Copy-number variations associated with neuropsychiatric conditions. Nature 2008, 455:919-23.
3. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-72.
4. Lee G, Studer L: Induced pluripotent stem cell technology for the study of human disease. Nat Methods 2010, 7:25-7.
5. Marchetto MC, Winner B, Gage FH: Pluripotent stem cells in neurodegenerative and neurodevelopmental diseases. Hum Mol Genet 2010, 19:R71-6.
6. Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, Kim J, Aryee MJ, Ji H, Ehrlich LI, Yabuuchi A, Takeuchi A, Cunniff KC, Hongguang H, Mckinney-Freeman S, Naveiras O, Yoon TJ, Irizarry RA, Jung N, Seita J, Hanna J, Murakami P, Jaenisch R, Weissleder R, Orkin SH, Weissman IL, Feinber AP, Daley GQ: Epigeneticmemory in induced pluripotent stem cells. Nature 2010, 467:285-90.
7. Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, Lensch MW, Cowan C, Hochedlinger K, Daley GQ: Disease-specific induced pluripotent stem cells. Cell 2008, 134:877-86.
8. Urbach A, Bar-Nur O, Daley GQ, Benvenisty N: Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell 2010, 6:407-11.
9. Hotta A, Cheung AY, Farra N, Vijayaragavan K, Séguin CA, Draper JS, Pasceri P, Maksakova IA, Mager DL, Rossant J, Bhatia M, Ellis J: Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Nat Methods 2009, 6:370-6.
10. Raff M: New routes into the human brain. Cell 2009, 139:1209-11.
11. Hanna J, Cheng AW, Saha K, Kim J, Lengner CJ, Soldner F, Cassady JP, Muffat J, Carey BW, Jaenisch R: Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc Natl Acad Sci U S A 2010, 107:9222-7.
12. Tchieu J, Kuoy E, Chin MH, Trinh H, Patterson M, Sherman SP, Aimiuwu O, Lindgren A, Hakimian S, Zack JA, Clark AT, Pyle AD, Lowry WE, Plath K: Female human iPSCs retain an inactive X chromosome. Cell Stem Cell 2010, 7:329-42.
13. Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, Studer L: Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 2009, 27:275-80.
14. Hu BY, Weick JP, Yu J, Ma LX, Zhang XQ, Thomson JA, Zhang SC: Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci U S A 2010, 107:4335-40.
15. Zhang XQ, Zhang SC: Differentiation of neural precursors and dopaminergic neurons from human embryonic stem cells. Methods Mol Biol 2010, 584:355-66.
16. Li XJ, Zhang X, Johnson MA, Wang ZB, Lavaute T, Zhang SC: Coordination of sonic hedgehog and Wnt signaling determines ventral and dorsal telencephalic neuron types from human embryonic stem cells. Development 2009, 136:4055-63.
17. Di Giorgio FP, Boulting GL, Bobrowicz S, Eggan KC: Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell 2008, 3:637-48.
18. Ballas N, Lioy DT, Grunseich C, Mandel G: Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat Neurosci 2009, 12:311-7.
19. Chen SK, Tvrdik P, Peden E, Cho S, Wu S, Spangrude G, Capecchi MR: Hematopoietic origin of pathological grooming in Hoxb8 mutant mice. Cell 2010, 141:775-85.
20. Buecker C, Chen H-H, Polo JM, Daheron L, Bu L, Barakat TS, Okwieka P, Porter A, Gribnau J, Hochedlinger K, Geijsen N: A murine ESC-like state facilitates transgenesis and homologous recombination in human pluripotent stem cells. Cell Stem Cell 2010, 6:535-46.
21. McCarthy SE, Makarov V, Kirov G, Addington AM, McClellan J, Yoon S, Perkins DO, Dickel DE, Kusenda M, Krastoshevsky O, Krause V, Kumar RA, Grozeva D, Malhotra D, Walsh T, Zackai EH, Kaplan P, Ganesh J, Krantz ID, Spinner NB, Roccanova P, Bhandari A, Pavon K, Lakshmi B, Leotta A, Kendall J, Lee YH, Vacic V, Gary S, Iakoucheva LM, et al.; Wellcome Trust Case Control Consortium: Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet 2009, 41:1223-7.
22. Närvä E, Autio R, Rahkonen N, Kong L, Harrison N, Kitsberg D, Borghese L, Itskovitz-Eldor J, Rasool O, Dvorak P, Hovatta O, Otonkoski T, Tuuri T, Cui W, Brüstle O, Baker D, Maltby E, Moore HD, Benvenisty N, Andrews PW, Yli-Harja O, Lahesmaa R: High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat Biotechnol 2010, 28:371-7.
23. Marchetto MC, Yeo GW, Kainohana O, Marsala M, Gage FH, Muotri AR: Transcriptional signature and memory retention of human-induced pluripotent stem cells. PLoS One 2009, 4:e7076.
24. Rastegar M, Hotta A, Pasceri P, Makarem M, Cheung AY, Elliott S, Park KJ, Adachi M, Jones FS, Clarke ID, Dirks P, Ellis J: MECP2 isoform-specific vectors with regulated expression for Rett syndrome gene therapy. PLoS One 2009, 4:e6810.
25. Ramocki MB, Zoghbi HY: Failure of neuronal homeostasis results in common neuropsychiatric phenotypes. Nature 2008, 455:912-8.
26. Ebert AD, Svendsen CN: Human stem cells and drug screening: opportunities and challenges. Nat Rev Drug Discov 2010, 9:367-72.
27. Ebert AD, Yu J, Rose FF Jr, Mattis VB, Lorson CL, Thomson JA, Svendsen CN: Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009, 457:277-80.
28. Lee G, Papapetrou EP, Kim H, Chambers SM, Tomishima MJ, Fasano CA, Ganat YM, Menon J, Shimizu F, Viale A, Tabar V, Sadelain M, Studer L: Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 2009, 461:402-6.
29. Dragunow M: High-content analysis in neuroscience. Nat Rev Neurosci 2008, 9:779-88.
30. Stirman JN, Brauner M, Gottschalk A, Lu H: High-throughput study of synaptic transmission at the neuromuscular junction enabled by optogenetics and microfluidics. J Neurosci Methods 2010, 191:90-3.
31. Weick JP, Johnson MA, Skroch SP, Williams JC, Deisseroth K, Zhang SC: Functional control of transplantable human ESC-derived neurons via optogenetic targeting. Stem Cells 2010, 28:2008-16.